Holdings
Eiger Wealth Management, LLC
As of Sep 30, 2026, Eiger Wealth Management, LLC reported 17 positions worth US$4.62M. Largest: Schwab U.S. Large-Cap ETF, iShares MSCI USA Quality Factor ETF and Broadcom Inc. What it bought and sold, with each filing.
Holdings
- Positions
- 17
- Value as reported
- US$4.62M
- Holdings as of
- Sep 30, 2026
- Last filed
- Nov 4, 2026
| Company | Shares | Value as reported | % of company | % of portfolio | Change | As of |
|---|---|---|---|---|---|---|
| Schwab U.S. Large-Cap ETF AMEX:SCHX | 32,981 | US$989K | 21.4% | +90 | Sep 30, 2026 | |
| iShares MSCI USA Quality Factor ETF CBOE:QUAL | 1,944 | US$432K | 9.4% | +1 | Sep 30, 2026 | |
| Broadcom Inc. NASDAQ:AVGO | 1,017 | US$357K | <0.01% | 7.7% | New | Sep 30, 2026 |
| Zentalis Pharmaceuticals, Inc. NASDAQ:ZNTL | 115K | US$319K | 0.12% | 6.9% | +29,095 | Sep 30, 2026 |
| Meta Platforms, Inc. NASDAQ:META | 436 | US$316K | <0.01% | 6.8% | New | Sep 30, 2026 |
| NVIDIA Corporation NASDAQ:NVDA | 1,344 | US$307K | <0.01% | 6.6% | New | Sep 30, 2026 |
| Amazon.com, Inc. NASDAQ:AMZN | 1,124 | US$280K | <0.01% | 6.1% | +212 | Sep 30, 2026 |
| Vanguard Morningstar Growth ETF AMEX:VUG | 3,084 | US$278K | 6.0% | No change | Sep 30, 2026 | |
| Lam Research Corporation NASDAQ:LRCX | 701 | US$230K | <0.01% | 5.0% | New | Sep 30, 2026 |
| Immunome, Inc. NASDAQ:IMNM | 10,587 | US$228K | 4.9% | No change | Sep 30, 2026 | |
| TriNet Group, Inc. NYSE:TNET | 3,532 | US$221K | <0.01% | 4.8% | New | Sep 30, 2026 |
| GAMCO Natural Resources, Gold & Income Trust NYSE:GNT | 20,212 | US$176K | 0.12% | 3.8% | No change | Sep 30, 2026 |
| GAMCO Global Gold. Natural Resources & Income Trust AMEX:GGN | 23,803 | US$126K | 0.02% | 2.7% | No change | Sep 30, 2026 |
| Morgan Stanley Emerging Markets Domestic Debt Fund Inc NYSE:EDD | 23,510 | US$124K | 0.04% | 2.7% | No change | Sep 30, 2026 |
| Templeton Emerging Markets Income Fund NYSE:TEI | 18,500 | US$114K | 0.04% | 2.5% | No change | Sep 30, 2026 |
| Saba Capital Income & Opportunities Fund II NYSE:SABA | 12,250 | US$97,633 | 0.04% | 2.1% | No change | Sep 30, 2026 |
| Fate Therapeutics, Inc. NASDAQ:FATE | 10,000 | US$23,700 | <0.01% | 0.51% | No change | Sep 30, 2026 |